use
xpert
flu
assay
becam
awar
falseneg
result
studi
aim
analyz
caus
falseneg
result
one
hundr
fiftynin
respiratori
specimen
test
xpert
flu
assay
multiplex
revers
transcriptionpolymeras
chain
reaction
rtpcr
respiratori
virus
discord
specimen
test
influenza
ab
rgene
assay
one
hundr
fiftytwo
specimen
yield
concord
result
influenza
b
respect
fifteen
specimen
test
neg
xpert
flu
assay
posit
multiplex
rtpcr
posit
result
confirm
specimen
influenza
ab
rgene
assay
xpert
flu
assay
amplif
curv
endpoint
suggest
falseneg
result
mainli
due
erron
automat
result
interpret
report
falseneg
result
xpert
flu
assay
due
erron
automat
result
interpret
care
analysi
amplif
curv
endpoint
need
avoid
report
falseneg
result
rapid
diagnosi
influenza
use
earli
administr
antivir
therapi
infect
control
avoid
unnecessari
antibiot
use
multiplex
rtpcr
detect
respiratori
pathogen
commerci
avail
use
routin
diagnost
respiratori
infect
gharabaghi
et
al
vallier
renaud
advantag
simultan
detect
panel
differ
respiratori
pathogen
howev
timeconsum
usual
perform
larg
seri
specimen
therebi
prolong
time
result
avail
physician
charg
patient
rapid
molecular
diagnost
assay
develop
nie
et
al
novakweekley
et
al
perform
upon
demand
singl
specimen
usual
yield
result
less
two
hour
exampl
xpert
flu
test
cepheid
franc
use
xpert
flu
test
cepheid
franc
urgent
diagnost
influenza
becam
awar
appar
falseneg
result
therefor
initi
current
studi
order
systemat
analyz
caus
falseneg
result
octob
april
specimen
sent
laboratori
rapid
influenza
test
xpert
flu
assay
specimen
sent
multiplex
rtpcr
detect
respiratori
virus
respiratori
specimen
test
xpert
flu
assay
multiplex
rtpcr
respiratori
virus
specimen
sent
intens
care
unit
n
depart
pulmonari
medicin
n
pediatr
n
hematolog
n
infecti
diseas
n
geriatr
n
emerg
medicin
n
less
frequent
depart
n
nasopharyng
swab
bronchoalveolar
lavag
nasopharyng
aspir
expector
bronchopulmonari
secret
tracheal
aspir
remel
microtest
transport
roch
franc
use
transport
medium
specimen
test
assay
analyz
current
studi
xpert
flu
assay
multiplex
rtpcr
respiratori
virus
prescrib
simultan
physician
charg
patient
specimen
cohort
case
specimen
cohort
b
laboratori
physician
addit
prescrib
multiplex
rtpcr
respiratori
virus
shehe
doubt
xpert
flu
assay
result
ie
neg
result
indic
automat
interpret
amplif
curv
visibl
endpoint
valu
elev
nucleic
acid
extract
submit
commerci
avail
multiplex
rtpcr
screen
panel
respiratori
viral
pathogen
includ
influenza
viru
b
respiratori
syncyti
viru
b
human
adenoviru
hadv
human
metapneumoviru
coronavirus
parainfluenza
viru
rhinoviru
abc
human
enteroviru
bocaviru
anyplex
ii
detect
seegen
seoul
korea
octob
februari
assay
perform
accord
manufactur
instruct
assay
contain
intern
control
amplif
cycl
perform
detect
limit
indic
manufactur
copi
per
reaction
result
indic
invalid
neg
posit
semiquantit
result
weakli
posit
intermedi
strongli
posit
specimen
februari
april
allplex
respiratori
panel
seegen
seoul
korea
use
accord
manufactur
instruct
techniqu
multiplex
realtim
onestep
rtpcr
detect
influenza
viru
b
human
respiratori
syncyti
viru
b
subtyp
influenza
viru
human
influenza
viru
subtyp
contain
intern
control
fortyf
amplif
cycl
perform
result
indic
invalid
neg
posit
latter
case
threshold
cycl
specifi
detect
limit
indic
manufactur
copi
per
reaction
xpert
flu
assay
cepheid
franc
use
genexpert
instrument
octob
decemb
genexpert
infin
instrument
thereaft
cepheid
franc
accord
manufactur
instruct
briefli
respiratori
specimen
ad
cartridg
lysi
specimen
purif
amplif
nucleic
acid
cycl
well
detect
target
sequenc
fulli
autom
abovement
instrument
result
interpret
genexpert
instrument
indic
posit
neg
invalid
case
posit
result
threshold
cycl
specifi
furthermor
amplif
curv
endpoint
valu
display
techniqu
includ
detect
influenza
influenza
subtyp
influenza
b
viru
sensit
indic
manufactur
depend
viru
strain
least
tissu
cultur
infect
dose
tcid
influenza
influenza
b
avail
nucleic
acid
extract
store
specimen
yield
discord
result
two
assay
describ
n
submit
influenza
ab
rgene
assay
argen
biomerieux
franc
assay
perform
accord
manufactur
instruct
run
realtim
pcr
system
appli
biosystem
thermofish
franc
amplif
cycl
sensit
indic
manufactur
depend
viru
strain
least
influenza
influenza
b
median
mean
quantit
variabl
calcul
quantit
variabl
compar
use
mannwhitney
u
test
ibm
spss
statist
version
ibm
usa
p
b
consid
signific
studi
period
specimen
yield
posit
result
influenza
influenza
b
xpert
flu
assay
specimen
yield
neg
result
influenza
b
specimen
also
test
multiplex
rtpcr
respiratori
virus
specimen
object
current
studi
xpert
flu
assay
multiplex
rtpcr
respiratori
virus
prescrib
simultan
physician
charg
patient
specimen
cohort
case
specimen
cohort
b
laboratori
physician
addit
prescrib
multiplex
rtpcr
respiratori
virus
shehe
doubt
xpert
flu
assay
result
cohort
specimen
test
posit
influenza
specimen
test
posit
influenza
b
respect
techniqu
five
specimen
gave
posit
result
influenza
specimen
gave
posit
result
influenza
b
multiplex
rtpcr
respiratori
virus
neg
result
xpert
flu
assay
detail
split
assay
shown
tabl
cohort
b
specimen
test
concordantli
neg
assay
wherea
specimen
test
posit
influenza
b
respect
allplex
respiratori
panel
neg
flu
xpert
assay
discord
specimen
investig
detail
tabl
nucleic
acid
specimen
avail
test
influenza
ab
rgene
assay
gave
posit
result
influenza
ab
rgene
assay
thu
confirm
result
multiplex
rtpcr
tabl
four
three
discord
specimen
weakli
posit
multiplex
rtpcr
respiratori
virus
influenza
ab
rgene
assay
respect
defin
threshold
cycl
tabl
howev
allplex
respiratori
panel
posit
specimen
concord
discord
analyz
median
ct
valu
discord
specimen
significantli
higher
concordantli
posit
specimen
vs
p
supplementari
tabl
semiquantit
result
concordantli
posit
discord
specimen
anyplex
ii
assay
posit
specimen
similar
supplementari
tabl
interestingli
discord
result
typic
amplif
curv
visibl
amplif
plot
xpert
flu
assay
exampl
shown
specimen
influenza
fig
b
specimen
influenza
b
fig
doubt
curv
visibl
discord
result
shown
specimen
influenza
supplementari
fig
b
specimen
influenza
b
supplementari
fig
xpert
flu
assay
indic
endpoint
valu
correspond
maximum
fluoresc
rel
fluoresc
unit
concordantli
posit
specimen
endpoint
valu
rang
influenza
n
influenza
b
n
influenza
discord
specimen
endpoint
valu
equal
higher
influenza
xpert
flu
assay
endpoint
valu
influenza
b
tabl
six
influenza
b
discord
specimen
endpoint
valu
equal
higher
influenza
b
endpoint
valu
influenza
tabl
specimen
endpoint
valu
equal
higher
show
typic
curv
amplif
plot
endpoint
valu
xpert
flu
assay
compar
concordantli
neg
specimen
trueneg
discord
result
falseneg
statist
signific
differ
p
b
supplementari
tabl
contrast
falseneg
specimen
trueneg
specimen
endpoint
valu
equal
higher
three
endpoint
valu
equal
higher
influenza
b
suggest
nonspecif
endpoint
elev
supplementari
tabl
specimen
endpoint
valu
equal
higher
influenza
b
endpoint
valu
equal
higher
influenza
subtyp
also
suggest
nonspecif
endpoint
elev
supplementari
tabl
specimen
endpoint
valu
equal
higher
show
doubt
amplif
curv
wherea
six
show
amplif
curv
supplementari
tabl
taken
togeth
data
suggest
falseneg
trueneg
specimen
differenti
endpoint
valu
amplif
curv
analyz
detail
current
studi
initi
investig
discord
result
differ
techniqu
use
diagnosi
influenza
although
overal
percentag
concord
result
high
specimen
yield
neg
result
xpert
flu
assay
posit
result
multiplex
rtpcr
respiratori
virus
one
specimen
discord
result
specimen
tabl
tracheal
aspir
packag
insert
xpert
flu
assay
indic
nasal
aspirateswash
nasopharyng
swab
specimen
use
assay
therefor
discord
result
case
specimen
might
tracheal
aspir
appropri
specimen
type
test
xpert
flu
assay
influenza
ab
rgene
assay
perform
avail
discord
specimen
confirm
multiplex
rtpcr
assay
result
case
therefor
result
xpert
flu
assay
consid
falseneg
xpert
flu
assay
contain
intern
control
spc
fig
supplementari
fig
posit
discord
specimen
exclud
pcr
inhibit
reason
falseneg
result
lack
sensit
xpert
flu
assay
could
caus
falseneg
result
find
support
hypothesi
median
ct
valu
falseneg
specimen
significantli
higher
concordantli
posit
specimen
supplementari
tabl
howev
sensit
xpert
flu
assay
previous
report
higher
compar
anoth
molecular
assay
duga
et
al
novakweekley
et
al
discord
result
studi
obtain
comparison
allplex
respiratori
panel
tabl
possibl
explan
might
allplex
respiratori
panel
sensit
anyplex
assay
assay
use
previous
publish
studi
howev
accord
packag
insert
sensit
allplex
respiratori
panel
higher
anyplex
assay
data
provid
manufactur
packag
insert
xpert
flu
rgene
assay
demonstr
sensit
assay
vari
differ
influenza
viru
type
strain
although
packag
insert
anyplex
allplex
respiratori
panel
assay
mention
sensit
assay
vari
differ
viru
type
strain
probabl
case
therefor
differ
sensit
assay
detect
certain
viru
strain
may
partli
explain
discord
result
xpert
flu
assay
assay
interestingli
discord
specimen
differ
ct
influenza
ab
rgene
assay
allplex
respiratori
panel
might
also
due
differ
sensit
two
assay
detect
differ
influenza
viru
strain
failur
assay
detect
specif
viru
strain
due
mutat
primer
probe
region
previous
report
binnick
et
al
rule
reason
falseneg
result
xpert
flu
assay
primer
probe
sequenc
known
us
howev
current
studi
falseneg
result
detect
influenza
b
therefor
find
support
hypothesi
falseneg
result
due
primer
probe
mismatch
furthermor
analysi
detail
xpert
flu
assay
suggest
tabl
result
multiplex
rtpcr
respiratori
virus
xpert
flu
assay
cohort
erron
automat
interpret
main
caus
falseneg
result
fact
detail
analysi
endpoint
valu
amplif
curv
suggest
target
amplif
detect
occur
specimen
falseneg
result
although
automat
result
interpret
indic
neg
becom
awar
problem
therefor
care
verifi
amplif
curv
zoom
endpoint
valu
specimen
report
specimen
visibl
curv
weakli
posit
indetermin
approach
allow
us
avoid
report
falseneg
result
discord
specimen
describ
current
studi
importantli
sinc
februari
approach
prospect
appli
specimen
test
routin
xpert
flu
assay
total
specimen
includ
specimen
mention
interpret
neg
automat
result
interpret
xpert
flu
assay
report
weakli
posit
n
indetermin
n
laboratori
physician
howev
retrospect
review
amplif
curv
zoom
xpert
flu
assay
result
perform
studi
period
n
therefor
might
miss
number
falseneg
result
taken
togeth
find
suggest
automat
result
interpret
complet
reliabl
could
repres
concern
case
use
point
care
test
suggest
automat
result
interpret
chang
report
indetermin
instead
neg
case
amplif
curv
low
amplitud
slightli
elev
endpoint
would
alert
user
could
come
person
interpret
care
review
amplif
curv
endpoint
data
decid
whether
report
assay
result
perform
anoth
assay
recommend
test
second
specimen
studi
follow
limit
test
respiratori
specimen
techniqu
done
either
prescrib
physician
charg
patient
cohort
laboratori
physician
charg
result
valid
doubt
result
xpert
flu
assay
cohort
b
doubt
occur
amplif
curv
visibl
endpoint
valu
elev
automat
result
interpret
indic
neg
furthermor
doubt
aros
first
specimen
yield
neg
result
second
specimen
patient
yield
posit
result
xpert
flu
assay
nine
multiplex
rtpcr
posit
specimen
yield
neg
result
xpert
flu
assay
cohort
cohort
b
respect
enrich
discord
result
cohort
b
reason
result
cohort
b
present
separ
conclus
analyz
specimen
falseneg
result
xpert
flu
assay
show
mainli
due
erron
automat
interpret
user
techniqu
awar
problem
care
interpret
amplif
curv
endpoint
data
sole
reli
automat
result
interpret
supplementari
data
articl
found
onlin
http
dx
fund
work
support
de
leduc
national
de
lenseign
et
de
la
recherch
lill
equip
daccueil
centr
hospitali
et
universitair
de
lill
fund
sourc
involv
studi
design
data
collect
analysi
write
report
